Guided spiritual care sessions for adults with acute leukemia
Official title: Spiritual Care to Optimize Relationships and Experience in Adults With Acute Leukemia (SCORE Trial)
Run by University of Chicago · NCT07405424 · Data updated 2026-11-12
This will test whether adding guided spiritual care sessions helps adults hospitalized for initial treatment of acute leukemia compared with standard inpatient spiritual care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | University of Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | June 20, 2026 |
| Main results expected | June 16, 2028 |
| Study ends | June 16, 2028 |
| Registry record updated | March 4, 2026 |
| Trial ID | NCT07405424 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with newly diagnosed acute leukemia (AML or ALL) who are hospitalized for initial therapy, can read and understand English, and are able to provide informed consent.
✕Probably not a fit
Patients with relapsed or refractory leukemia, those unable to participate in or comply with spiritual sessions, or those with cognitive impairment that prevents participation are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized intervention assigns adults with newly diagnosed acute leukemia who are hospitalized for initial therapy to either usual inpatient spiritual care or to receive study-specific guided spiritual sessions. The guided sessions are delivered during the inpatient stay and aim to be integrated into the patient's care plan while feasibility, acceptability, and patient-reported outcomes are tracked. Eligible participants are English-speaking adults (18+) with AML or ALL who can provide informed consent, while patients with relapsed or refractory disease or cognitive deficits that limit participation are excluded. The trial is conducted at the University of Chicago Medicine Comprehensive Cancer Center.
Why it matters
Potential benefit: If successful, integrating guided spiritual sessions could improve patients' spiritual well-being, coping, and overall experience during intensive leukemia treatment.
How similar studies have gone: Prior research in cancer and palliative care has shown that spiritual care interventions can improve spiritual well‑being and coping, but randomized evidence specifically in hospitalized acute leukemia patients is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria * Adults (18 years or older) * Diagnosis of Acute Leukemia (AML or ALL) undergoing inpatient initial therapy * Ability to read, understand, and speak the English language * Ability to understand and the willingness to sign a written informed consent document Exclusion criteria * Unable to comply with spiritual care intervention * Relapsed or refractory acute leukemia * Cognitive deficits that limit participation and survey questionnaire completion
Where it's running
-
UChicago Medicine Comprehensive Cancer Center
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Wendy Stock — University of Chicago
- Study coordinator: Clinical Trials Intake
- Email: cancerclinicaltrials@bsd.uchicago.edu
- Phone: 1-855-702-8222
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Genetics of Blood Cancers in the U.S. population
This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.
-
Strength Training for Kids with Acute Lymphoblastic Leukemia and Lymphoblastic L lymphoma
Researchers are testing a structured strength-training program for children and teens recently diagnosed with ALL or lymphoblastic lymphoma to see if it helps with weight gain and physical function during treatment.
-
Cord blood transplant for children and young adults with blood cancers.
This study will test whether a cord blood transplant given as a first or second transplant can help children and young adults with leukemia, myelodysplasia, or lymphoma who lack a matched donor.
-
Cohort for people with chronic myelomonocytic leukemia
This project will collect blood and bone marrow samples from adults with chronic myelomonocytic leukemia at diagnosis and during disease changes to create an anonymized biobank researchers can use to test new questions.
-
Triple-drug approach for AML using eganelisib with azacitidine and venetoclax
This early-stage trial tests whether adding eganelisib to azacitidine and venetoclax can be safe and show signs of benefit in adults with acute myeloid leukemia.
-
Revumenib with Mezigdomide for relapsed or refractory acute leukemia
This trial will test whether combining revumenib and mezigdomide is safe for people aged 12 and older with relapsed or refractory acute leukemia that has KMT2A, NUP98, or NPM1 genetic changes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.